Related

The Biomedical Networking Research Center of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) is one of the 11 thematic areas of CIBER. CIBER groups some of the main Spanish research groups (more than 400) in biomedicine, located in more than 100 institutions distributed around Spain.

About

CIBER-BBN’s research program is organized in three different scientific areas and six strategic lines. The area of Bioengineering consists of the strategic lines of Multimodal Diagnosis and Smart Devices, the area of Biomaterials of the lines of Advanced Therapies and Implants, while the area of Nanomedicine includes the strategic lines of Therapeutic Nanoconjugates and Biosensors.
CIBER -BBN research groups are continuously evaluated under the light of scientific excellence by using markers such as their number of publications (>500 per year), but also for their activities in obtaining financing in competitive calls, the transfer of technology and their relations with the private sector. During its rather short life, CIBER-BBN was awarded over 150 grants and raised over € 200 millions in competitive calls (HEALTH, NMP, PEOPLE, ERA- NET EuroNanoMed and ERC Starting and Advanced Grants), which gives an idea of the enormous potential of the research teams it comprises.
CIBER-BBN manages also NANBIOSIS (Infrastructure for the Production and Characterization of Biomaterials, Nanomaterials and Systems in Biomedicine), which has been recognized as an Unique Scientific-Technological Infrastructure (ICTS) by the Spanish Government.

Available technologies

TRL: 3
Availability: other
Status: EP Application
A stretchable opto-mechanical material composed by a metallic and or dielectric nanostructure array embedded into a wrinkled elastomer
TRL: 3
Availability: other
Status: EP Application
A toolbox for SPECT quantification in dopaminergic system (tQUDOSY)
TRL: 3
Availability: other
Status: other
Acquisition device to limit leakage current in electrophysiological signal recording devices
TRL: 3
Availability: other
Status: EP Application
Actively targeted polymeric micelles for drug and gene delivery
TRL: 3
Availability: other
Status: other
TRL: 3
Availability: other
Status: EP Application
Device and method of continuous insulin infusion dose with a hybrid corrective and predictive PID monitoring
TRL: 2
Availability: other
Status: other
Devices and methods for multiplexing liquid in biosensor micro-chambers
TRL: 3
Availability: other
Status: other
Electrochemical sensor systems for sensing analytical reactions and biological operations and methods
TRL: 4
Availability: other
Status: EP Application
Graphene transistor system for measuring electrophysiological signals
TRL: 3
Availability: other
Status: other
Haptens, antibodies and method to detect psedumonas aeruginosa infections
TRL: 3
Availability: other
Status: other
Injectable material for the regeneration of articular cartilage
TRL: 3
Availability: other
Status: other
TRL: 3
Availability: Licensing
Status: EP Application
Material platforms for simultaneous solid-phase presentation of boron and cell adhesion domains as antitumor strategy for carcinomas
TRL: 3
Availability: other
Status: EP Application
Method for diagnosis, prognosis and monitoring of Alzheimer disease using metabolomic techniques
TRL: 3
Availability: other
Status: other
Method for rapid detection of Candida auris and diagnosis of infection caused by this pathogen
TRL: 3
Availability: other
Status: other
Method for the detection and fast diagnosis of Staphylococcus aureus
TRL: 3
Availability: other
Status: other
TRL: 3
Availability: other
Status: other
Methods and systems for measuring a stress indicator, and for determining a level of stress in an individual
TRL: 3
Availability: other
Status: other
TRL: 3
Availability: other
Status: other
Nanovesicles and its use for nucleic acid delivery
TRL: 3
Availability: other
Status: EP Application
New combinations of boron compounds and adjuvants for the treatment of pathophysiological conditions and muscle regeneration
TRL: 3
Availability: other
Status: PCT Application
PCR-less technologies for rapid detection of SARS-CoV-2 and influenza RNAs
TRL: 3
Availability: other
Status: EP Application
Photoisomerizable derivatives of dihydrofolate reductase inhibitors
TRL: 3
Availability: other
Status: other
Porous material for the detection of candida albicans, its method of preparation and diagnostic method that use it
TRL: 3
Availability: other
Status: other
Procedure for the exfoliation and transfer of graphene from a doped silicon carbide substrate to another substrate
TRL: 2
Availability: other
Status: other
Protein nano- or microparticles as artificial inclusion bodies for drug delivey
TRL: 3
Availability: other
Status: EP Application
Self-assembled functional acrylic copolymers and terpolymers and their use as vehicles of bioactive compounds
TRL: 3
Availability: other
Status: other
SOFTWARE LEX-hMC. Low Energy X-rays Hybrid MC for Fast Dose Computation
TRL: 3
Availability: other
Status: other
Synthetic hydrogel and its use for immunotherapy and 3D-printing
TRL: 3
Availability: other
Status: other
Tools for the statistical analysis of PET studies in refractory epilepsy (tSAPRE)
TRL: 3
Availability: other
Status: other
Use of an inhibitor of adrenomedullin for the manufacture of a drug useful in the prevention and treatment of disease that reduce bone density
TRL: 3
Availability: other
Status: other
Use of boron and its derivatives for the treatment of muscular dystrophies
TRL: 3
Availability: other
Status: other